Social and Behavioral Research Branch, National Human Genome Research Institute, Bethesda, Maryland.
University of Technology Sydney, Graduate School of Health, Australia.
Am J Med Genet A. 2019 May;179(5):762-769. doi: 10.1002/ajmg.a.61107. Epub 2019 Mar 1.
This study explored patients' experiences and perceptions of living with thalassemia (an inherited hematologic disorder), perceptions of social stigma, and impact on disclosure decision-making. Semistructured, in-person interviews were conducted in Singapore with 30 individuals: 16 thalassemia major patients and 14 parents of children with thalassemia. Findings were indicative of felt or enacted stigma that may have influenced disclosure decisions. Although affected individuals commonly disclosed their thalassemia diagnosis to family members, they either downplayed the condition with or avoided disclosure to unrelated individuals. Disclosure outside the family occurred only in response to triggers, such as questions about absences due to medical care. Health professionals should provide anticipatory guidance about disclosure strategies when managing individuals with thalassemia.
本研究探讨了患者对地中海贫血(一种遗传性血液疾病)的生活体验和看法、对社会污名的看法,以及对披露决策的影响。在新加坡,对 30 个人进行了半结构化的现场访谈:16 名地中海贫血重症患者和 14 名儿童地中海贫血患者的家长。研究结果表明,可能有感觉到或实际的污名影响了披露决定。尽管受影响的个人通常会向家人透露他们的地中海贫血诊断,但他们要么淡化病情,要么避免向无关人员透露。只有在出现一些触发因素时,如因医疗原因缺勤的问题,才会向家庭以外的人披露病情。医疗保健专业人员在管理地中海贫血患者时,应提供有关披露策略的预期指导。